Eli Lilly develops, produces and markets pharmaceutical products for health care professionals, patients and consumers.Read more
Eli Lilly's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 34.2B. Over the last four quarters, Eli Lilly's revenue has grown by 15.9%. Specifically, in Q1 2022's revenue was $7.8B; in Q4 2021, it was $8B; in Q3 2021, it was $6.8B; in Q2 2021, Eli Lilly's revenue was $6.7B.